Skip to main content
SpringerLink
Log in

Methylenetetrahydrofolate reductase gene C677T, A1298C polymorphisms and pre-eclampsia risk: a meta-analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

To determine whether methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms are associated with pre-eclampsia susceptibility. Literature searches of the Pubmed, Embase, BIOSIS Previews and Web of Science were conducted to identify all eligible articles up to January 18th, 2013. The pooled odds ratios (ORs) with 95 % confidence intervals (CIs) of five genetic models were calculated by fixed-effects or random-effects model. Publication bias, subgroup analysis, meta-regression and sensitivity analysis were also performed. A number of 49 studies including 51 samples consisted of 18,009 subjects (6,238 patients and 11,771 controls) were finally included. MTHFR C677T allele (TT or CT) carriers were 1.12 times more likely to develop pre-eclampsia (95 % CI 1.04–1.21) compared with 677CC homozygous individuals. Similar results were obtained under other genetic models. Restricted to severe pre-eclampsia, there was an increased risk for 677TT homozygotes compared with 677CC homozygotes (OR 1.43; 95 % CI 1.12–1.83). Subgroup analysis revealed a significant positive association between the C677T polymorphism (TT or CT) and pre-eclampsia in Asians (OR 1.41; 95 % CI 1.11–1.79) and white population (OR 1.14; 95 % CI 1.03–1.25). Meta-regression showed that study population, blinded genotyping, matching of cases and controls were not substantial sources of heterogeneity. For the MTHFR A1298C, ORs for all genetic models yielded a null association. This meta-analysis suggests that the MTHFR 677T allele might be associated with increased pre-eclampsia risk in Asian and white ethnicity and the subgroup of severe pre-eclampsia, while no association is observed between the MTHFR A1298C polymorphism and pre-eclampsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, de Swiet M, Fletcher G, Jokinen M, Murphy D, Nelson-Piercy C, Osgood V, Robson S, Shennan A, Tuffnell A, Twaddle S, Waugh J (2005) The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 330(7491):576–580

    Article  PubMed Central  PubMed  Google Scholar 

  2. Bulletins–Obstetrics ACoP (2002) ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol 99(1):159–167

  3. Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33(3):130–137. doi:10.1053/j.semperi.2009.02.010

    Article  PubMed  Google Scholar 

  4. Bellamy L, Casas JP, Hingorani AD, Williams DJ (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335(7627):974. doi:10.1136/bmj.39335.385301.BE

    Article  PubMed Central  PubMed  Google Scholar 

  5. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376(9741):631–644. doi:10.1016/s0140-6736(10)60279-6

    Article  PubMed  Google Scholar 

  6. Noris M, Perico N, Remuzzi G (2005) Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 1(2):98–114. doi:10.1038/ncpneph0035 quiz 120

    Article  CAS  PubMed  Google Scholar 

  7. Bailey LB, Gregory JF 3rd (1999) Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 129(5):919–922

    CAS  PubMed  Google Scholar 

  8. Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9(8):652–656

    Article  CAS  PubMed  Google Scholar 

  9. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10(1):111–113. doi:10.1038/ng0595-111

    Article  CAS  PubMed  Google Scholar 

  10. Fletcher O, Kessling AM (1998) MTHFR association with arteriosclerotic vascular disease? Hum Genet 103(1):11–21

    Article  CAS  PubMed  Google Scholar 

  11. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62(5):1044–1051. doi:10.1086/301825

    Article  PubMed Central  PubMed  Google Scholar 

  12. Patrick TE, Powers RW, Daftary AR, Ness RB, Roberts JM (2004) Homocysteine and folic acid are inversely related in black women with preeclampsia. Hypertension 43(6):1279–1282. doi:10.1161/01.HYP.0000126580.81230.da

    Article  CAS  PubMed  Google Scholar 

  13. Zhang XYSD, Sun J (2008) The relationship between plasma homocysteine and preeclampsia. J Perinat Med 114:245–248

    Google Scholar 

  14. Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, Roberts JM (1998) Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 179(6 Pt 1):1605–1611

    Article  CAS  PubMed  Google Scholar 

  15. Roberts JM, Taylor RN, Goldfien A (1991) Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 4(8):700–708

    CAS  PubMed  Google Scholar 

  16. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM (2000) Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the hordaland homocysteine study. Am J Clin Nutr 71(4):962–968

    CAS  PubMed  Google Scholar 

  17. Mikael LG, Pancer J, Jiang X, Wu Q, Caudill M, Rozen R (2012) Low dietary folate and methylenetetrahydrofolate reductase deficiency may lead to pregnancy complications through modulation of apoai and ifn-gamma in spleen and placenta, and through reduction of methylation potential. Mol Nutr Food Res. doi:10.1002/mnfr.201200152

    Google Scholar 

  18. Zusterzeel PL, Visser W, Blom HJ, Peters WH, Heil SG, Steegers EA (2000) Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome. Hypertens Pregnancy 19(3):299–307

    Article  CAS  PubMed  Google Scholar 

  19. Kosmas IP, Tatsioni A, Ioannidis JP (2004) Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 22(9):1655–1662

    Article  CAS  PubMed  Google Scholar 

  20. Lin J, August P (2005) Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105(1):182–192. doi:10.1097/01.AOG.0000146250.85561.e9

    Article  PubMed  Google Scholar 

  21. Xia XP, Chang WW, Cao YX (2012) Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to pre-eclampsia. Hypertens Res. doi:10.1038/hr.2012.117

    PubMed  Google Scholar 

  22. Demir SC, Evruke C, Ozgunen T, Kadayifci O, Altintas U, Kokangul S (2006) The relationship between pregnancy induced hypertension and congenital thrombophilia. Saudi Med J 27(8):1161–1166

    PubMed  Google Scholar 

  23. Stonek F, Hafner E, Philipp K, Hefler LA, Bentz EK, Tempfer CB (2007) Methylenetetrahydrofolate reductase C677T polymorphism and pregnancy complications. Obstet Gynecol 110(2 Pt 1):363–368. doi:10.1097/01.AOG.0000270122.13198.6f

    Article  CAS  PubMed  Google Scholar 

  24. Yoshida A, Miura K, Nakayama D, Masuzaki H (2008) Correlation between preeclampsia and prevalence of polymorphism of angiotensinogen, methyleneteterahydrofolate reductase and factor v, prothrombin genes among Japanese women. Acta Med Nagasak 53(2):37–41

    CAS  Google Scholar 

  25. Kahn SR, Platt R, McNamara H, Rozen R, Chen MF, Genest J Jr, Goulet L, Lydon J, Seguin L, Dassa C, Masse A, Asselin G, Benjamin A, Miner L, Ghanem A, Kramer MS (2009) Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal preeclampsia study. Obstet Gynecol Surv 64(6):366–368

    Article  Google Scholar 

  26. Mislanova C, Martsenyuk O, Huppertz B, Obolenskaya M (2011) Placental markers of folate-related metabolism in preeclampsia. Reproduction 142(3):467–476. doi:10.1530/rep-10-0484

    Article  CAS  PubMed  Google Scholar 

  27. Dissanayake VH, Sirisena ND, Weerasekera LY, Gammulla CG, Seneviratne HR, Jayasekara RW (2012) Candidate gene study of genetic thrombophilic polymorphisms in pre-eclampsia and recurrent pregnancy loss in Sinhalese women. J Obstet Gynaecol Res. doi:10.1111/j.1447-0756.2012.01846.x

    Google Scholar 

  28. Lykke JA, Bare LA, Olsen J, Lagier R, Arellano AR, Tong C, Paidas MJ, Langhoff-Roos J (2012) Thrombophilias and adverse pregnancy outcomes: results from the Danish national birth cohort. J Thromb Haemost 10(7):1320–1325. doi:10.1111/j.1538-7836.2012.04773.x

    Article  CAS  PubMed  Google Scholar 

  29. Li KZD, Xue Y, Sun Y, Chen L, Guo J, Zhang G, Li P (2000) The common C677T polymorphism in the methylenetetrahydrofolate reductase gene is associated with neural tube defects and preeclampsia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese. J Med Genet 17:76–78

    CAS  Google Scholar 

  30. Zhang ZHZR, Liu AM, Xu X, Liu ZH (2007) Study on eNOS gene and MTHFR gene polymorphisms in preeclampsia. J Birth Health Hered 15:21–23

    Google Scholar 

  31. Shen XNHY, Tang SH, Zhang CL, Chen WS (2009) The relationship between the polymorphism of MTHFR gene and pre-eclampsia. J Pract Obstet Gynecol 25:236–238

    Google Scholar 

  32. Prasmusinto D, Skrablin S, Hofstaetter C, Fimmers R, Van Der Ven K (2002) The methylenetetrahydrofolate reductase 677 C→T polymorphism and preeclampsia in two populations. Obstet Gynecol 99(6):1085–1092

    Article  CAS  PubMed  Google Scholar 

  33. Gray RD, Atkinson QD (2003) Language-tree divergence times support the Anatolian theory of Indo-European origin. Nature 426(6965):435–439. doi:10.1038/nature02029

    Article  CAS  PubMed  Google Scholar 

  34. Cavalli-Sforza LL, Feldman MW (2003) The application of molecular genetic approaches to the study of human evolution. Nat Genet 33(Suppl):266–275. doi:10.1038/ng1113

    Article  CAS  PubMed  Google Scholar 

  35. Nei M, Roychoudhury AK (1993) Evolutionary relationships of human populations on a global scale. Mol Biol Evol 10(5):927–943

    CAS  PubMed  Google Scholar 

  36. Cavalli-Sforza LL, Piazza A, Menozzi P, Mountain J (1988) Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data. Proc Natl Acad Sci USA 85(16):6002–6006

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2013) The Newcastle–Ottawa scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://www.medicine.mcgill.ca/rtamblyn/Readings/The%20Newcastle%20-%20Scale%20for%20assessing%20the%20quality%20of%20nonrandomised%20studies%20in%20meta-analyses.pdf. Accessed 13 Oct 2013

  38. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. doi:10.1136/bmj.327.7414.557

    Article  PubMed Central  PubMed  Google Scholar 

  39. Song F, Sheldon TA, Sutton AJ, Abrams KR, Jones DR (2001) Methods for exploring heterogeneity in meta-analysis. Eval Health Prof 24(2):126–151

    Article  CAS  PubMed  Google Scholar 

  40. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Salanti G, Amountza G, Ntzani EE, Ioannidis JP (2005) Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. EJHG 13(7):840–848

    Article  CAS  PubMed  Google Scholar 

  42. Trikalinos TA, Salanti G, Khoury MJ, Ioannidis JP (2006) Impact of violations and deviations in Hardy–Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol 163(4):300–309. doi:10.1093/aje/kwj046

    Article  PubMed  Google Scholar 

  43. Dalmaz CA, Santos KG, Botton MR, Tedoldi CL, Roisenberg I (2006) Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population. Blood Cells Mol Dis 37(2):107–110. doi:10.1016/j.bcmd.2006.07.005

    Article  CAS  PubMed  Google Scholar 

  44. Williams MA, Sanchez SE, Zhang C, Bazul V (2004) Methylenetetrahydrofolate reductase 677 C→T polymorphism and plasma folate in relation to pre-eclampsia risk among Peruvian women. J Matern Fetal Neonatal Med 15(5):337–344. doi:10.1080/14767050410001680037

    Article  CAS  PubMed  Google Scholar 

  45. Rajkovic A, Mahomed K, Rozen R, Malinow MR, King IB, Williams MA (2000) Methylenetetrahydrofolate reductase 677 C→T polymorphism, plasma folate, vitamin b(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol Genet Metab 69(1):33–39. doi:10.1006/mgme.1999.2952

    Article  CAS  PubMed  Google Scholar 

  46. Dusse LM, Carvalho MG, Braganca WF, Paiva SG, Godoi LC, Guimaraes DA, Fernandes AP (2007) Inherited thrombophilias and pre-eclampsia in Brazilian women. Eur J Obstet Gynecol Reprod Biol 134(1):20–23. doi:10.1016/j.ejogrb.2006.09.006

  47. Yilmaz H, Unlucerci Y, Gurdol F, Isbilen E, Isbir T (2004) Association of pre-eclampsia with hyperhomocysteinaemia and methylenetetrahydrofolate reductase gene C677T polymorphism in a Turkish population. Aust N Z J Obstet Gynaecol 44(5):423–427. doi:10.1111/j.1479-828X.2004.00283.x

    Article  PubMed  Google Scholar 

  48. O’Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH (1999) Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension 33(6):1338–1341

    Article  PubMed  Google Scholar 

  49. De Maat MP, Jansen MW, Hille ET, Vos HL, Bloemenkamp KW, Buitendijk S, Helmerhorst FM, Wladimiroff JW, Bertina RM, De Groot CJ (2004) Preeclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost 2(9):1588–1593. doi:10.1111/j.1538-7836.2004.00861.x

    Article  PubMed  Google Scholar 

  50. Rigo J Jr, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I, Papp Z (2000) Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of Factor V Leiden mutation and 5,10-methylenetetrahydrofolate reductase. Hypertens Pregnancy 19(2):163–172

    Article  CAS  PubMed  Google Scholar 

  51. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA (2002) Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 87(5):779–785

    CAS  PubMed  Google Scholar 

  52. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G, Di Minno G (1997) Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 77(6):1052–1054

    CAS  PubMed  Google Scholar 

  53. Pegoraro RJ, Chikosi A, Rom L, Roberts C, Moodley J (2004) Methylenetetrahydrofolate reductase gene polymorphisms in Black South Africans and the association with preeclampsia. Acta Obstet Gynecol Scand 83(5):449–454. doi:10.1111/j.0001-6349.2004.0355.x

    Article  PubMed  Google Scholar 

  54. Also-Rallo E, Lopez-Quesada E, Urreizti R, Vilaseca MA, Lailla JM, Balcells S, Grinberg D (2005) Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies. Eur J Obstet Gynecol Reprod Biol 120(1):45–52. doi:10.1016/j.ejogrb.2004.08.008

    Article  CAS  PubMed  Google Scholar 

  55. Jaaskelainen E, Keski-Nisula L, Toivonen S, Romppanen EL, Helisalmi S, Punnonen K, Heinonen S (2006) MTHFR C677T polymorphism is not associated with placental abruption or preeclampsia in Finnish women. Hypertens Pregnancy 25(2):73–80. doi:10.1080/10641950600745137

    Article  CAS  PubMed  Google Scholar 

  56. Davalos IP, Moran MC, Martinez-Abundis E, Gonzalez-Ortiz M, Flores-Martinez SE, Machorro V, Sandoval L, Figuera LE, Mena JP, Oliva JM, Tlacuilo-Parra JA, Sanchez-Corona J, Salazar-Paramo M (2005) Methylenetetrahydrofolate reductase C677T polymorphism and Factor V Leiden variant in Mexican women with preeclampsia/eclampsia. Blood Cells Mol Dis 35(1):66–69. doi:10.1016/j.bcmd.2005.03.008

    Article  CAS  PubMed  Google Scholar 

  57. Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR, Roberts JM (1999) Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Investig 6(2):74–79

    Article  CAS  PubMed  Google Scholar 

  58. Livingston JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM (2001) Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 185(1):153–157. doi:10.1067/mob.2001.114691

    Article  CAS  PubMed  Google Scholar 

  59. Kaiser T, Brennecke SP, Moses EK (2001) C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for pre-eclampsia/eclampsia among Australian women. Hum Hered 51(1–2):20–22

    Article  CAS  PubMed  Google Scholar 

  60. Perez-Mutul J, Gonzalez-Herrera L, Sosa-Cabrera T, Martinez-Olivares R (2004) A mutation in the 5,10-methylenetetrahydrofolate reductase gene is not associated with preeclampsia in women of Southeast Mexico. Arch Med Res 35(3):231–234. doi:10.1016/j.arcmed.2004.02.004

    Article  CAS  PubMed  Google Scholar 

  61. Kobashi G, Yamada H, Asano T, Nagano S, Hata A, Kishi R, Fujimoto S, Kondo K (2000) Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women. Am J Med Genet 93(2):122–125

    Article  CAS  PubMed  Google Scholar 

  62. Aggarwal S, Dimri N, Tandon I, Agarwal S (2011) Preeclampsia in north Indian women: the contribution of genetic polymorphisms. J Obstet Gynaecol Res 37(10):1335–1341. doi:10.1111/j.1447-0756.2010.01523.x

    Article  PubMed  Google Scholar 

  63. Laivuori H, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K (2000) 677 C→T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol 96(2):277–280

    Article  CAS  PubMed  Google Scholar 

  64. Kim YJ, Williamson RA, Murray JC, Andrews J, Pietscher JJ, Peraud PJ, Merrill DC (2001) Genetic susceptibility to preeclampsia: roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine (beta)-synthase, and Factor V Leiden mutation. Am J Obstet Gynecol 184(6):1211–1217

    Article  CAS  PubMed  Google Scholar 

  65. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T (1997) Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 34(6):525–526

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  66. Canto P, Canto-Cetina T, Juarez-Velazquez R, Rosas-Vargas H, Rangel-Villalobos H, Canizales-Quinteros S, Velazquez-Wong AC, Villarreal-Molina MT, Fernandez G, Coral-Vazquez R (2008) Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya–Mestizo women. Hypertens Res 31(5):1015–1019. doi:10.1291/hypres.31.1015

    Article  CAS  PubMed  Google Scholar 

  67. Lachmeijer AM, Arngrimsson R, Bastiaans EJ, Pals G, ten Kate LP, de Vries JI, Kostense PJ, Aarnoudse JG, Dekker GA (2001) Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 184(3):394–402

    Article  CAS  PubMed  Google Scholar 

  68. Chikosi AB, Moodley J, Pegoraro RJ, Lanning PA, Rom L (1999) 5,10-Methylenetetrahydrofolate reductase polymorphism in Black South African women with pre-eclampsia. Br J Obstet Gynaecol 106(11):1219–1220. doi:10.1111/j.1471-0528.1999.tb08152.x

    Article  CAS  PubMed  Google Scholar 

  69. Muetze S, Leeners B, Ortlepp JR, Kuse S, Tag CG, Weiskirchen R, Gressner AM, Rudnik-Schoeneborn S, Zerres K, Rath W (2008) Maternal Factor V Leiden mutation is associated with HELLP syndrome in Caucasian women. Acta Obstet Gynecol Scand 87(6):635–642. doi:10.1080/00016340802112740

    Article  CAS  PubMed  Google Scholar 

  70. Nagy B, Hupuczi P, Papp Z (2007) High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR. J Hum Hypertens 21(2):154–158. doi:10.1038/sj.jhh.1002122

    Article  CAS  PubMed  Google Scholar 

  71. Watanabe H, Hamada H, Yamakawa-Kobayashi K, Yoshikawa H, Arinami T (2001) Evidence for an association of the R485K polymorphism in the coagulation factor V gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate genes. Thromb Haemost 86(6):1594–1595

    CAS  PubMed  Google Scholar 

  72. Ibrahim ZM, Metawie MAE, El-Baz AM, El-Bahie MA (2011) Methylenetetrahydrofolate C677T polymorphism and pre-eclamptic Egyptian women. Middle East Fertil Soc J 17(2):105–110

    Article  Google Scholar 

  73. Rahimi Z, Malek-Khosravi S, Rahimi Z, Jalilvand F, Parsian A (2012) MTHFR C677T and eNOS G894T variants in preeclamptic women: contribution to lipid peroxidation and oxidative stress. Clin Biochem 42(1–2):143–147

    Google Scholar 

  74. Dogan OO, Simsek Y, Celen S, Danisman N (2011) Frequency of hereditary thrombophilia, anticoagulant activity, and homocysteine levels in patients with hemolysis, elevated liver functions and low thrombocyte count (HELLP) syndrome. J Obstet Gynaecol Res 37(6):527–533. doi:10.1111/j.1447-0756.2010.01397.x

    Article  PubMed  Google Scholar 

  75. Fabbro D, D’Elia AV, Spizzo R, Driul L, Barillari G, Di Loreto C, Marchesoni D, Damante G (2003) Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Gynecol Obstet Invest 56(1):17–22. doi:10.1159/000072326

    Article  CAS  PubMed  Google Scholar 

  76. Gerhardt A, Goecke TW, Beckmann MW, Wagner KJ, Tutschek B, Willers R, Bender HG, Scharf RE, Zotz RB (2005) The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia. J Thromb Haemost 3(4):686–691

    Article  CAS  PubMed  Google Scholar 

  77. Jarvenpaa J, Pakkila M, Savolainen ER, Perheentupa A, Jarvela I, Ryynanen M (2006) Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in Northern Finland. Gynecol Obstet Invest 62(1):28–32. doi:10.1159/000091814

    Article  CAS  PubMed  Google Scholar 

  78. Klai S, Fekih-Mrissa N, El Housaini S, Kaabechi N, Nsiri B, Rachdi R, Gritli N (2011) Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies. Blood Coagul Fibrinolysis 22(5):374–378. doi:10.1097/MBC.0b013e328344f80f

    Article  CAS  PubMed  Google Scholar 

  79. Levesque S, Moutquin JM, Lindsay C, Roy MC, Rousseau F (2004) Implication of an AGT haplotype in a multigene association study with pregnancy hypertension. Hypertension 43(1):71–78. doi:10.1161/01.hyp.0000104525.76016.77

    Article  CAS  PubMed  Google Scholar 

  80. Hiltunen LM, Laivuori H, Rautanen A, Kaaja R, Kere J, Krusius T, Paunio M, Rasi V (2009) Blood group AB and Factor V Leiden as risk factors for pre-eclampsia: a population-based nested case–control study. Thromb Res 124(2):167–173. doi:10.1016/j.thromres.2008.11.012

    Article  CAS  PubMed  Google Scholar 

  81. D’Elia AV, Driul L, Giacomello R, Colaone R, Fabbro D, Di Leonardo C, Florio P, Petraglia F, Marchesoni D, Damante G (2002) Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecol Obstet Investig 53(2):84–87

    Article  Google Scholar 

  82. Raijmakers MT, Zusterzeel PL, Steegers EA, Peters WH (2001) Hyperhomocysteinaemia: a risk factor for preeclampsia? Eur J Obstet Gynecol Reprod Biol 95(2):226–228

    Article  CAS  PubMed  Google Scholar 

  83. Staines-Urias E, Paez MC, Doyle P, Dudbridge F, Serrano NC, Ioannidis JP, Keating BJ, Hingorani AD, Casas JP (2012) Genetic association studies in pre-eclampsia: systematic meta-analyses and field synopsis. Int J Epidemiol 41(6):1764–1775. doi:10.1093/ije/dys162

    Article  PubMed  Google Scholar 

  84. Buurma AJ, Turner RJ, Driessen JH, Mooyaart AL, Schoones JW, Bruijn JA, Bloemenkamp KW, Dekkers OM, Baelde HJ (2013) Genetic variants in pre-eclampsia: a meta-analysis. Hum Reprod Update. doi:10.1093/humupd/dms060

    Google Scholar 

  85. Murphy RP, Donoghue C, Nallen RJ, D’Mello M, Regan C, Whitehead AS, Fitzgerald DJ (2000) Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 20(1):266–270

    Article  CAS  PubMed  Google Scholar 

  86. Mendilcioglu I, Bilgen T, Arikan Y, Keser I, Simsek M, Timuragaoglu A (2011) The association between inherited thrombophilias and pregnancy-related hypertension recurrence. Arch Gynecol Obstet 284(4):837–841. doi:10.1007/s00404-010-1756-y

    Article  PubMed  Google Scholar 

  87. Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ (2012) Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech 5(1):9–18. doi:10.1242/dmm.008516

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  88. Gifford RW, August PA, Cunningham G, Green LA, Lindheimer MD, McNellis D, Roberts JM, Sibai BM, Taler SJ (2000) Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183(1):S1–S22

    Article  Google Scholar 

  89. Chelbi ST, Vaiman D (2008) Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol 282(1–2):120–129. doi:10.1016/j.mce.2007.11.022

    Article  CAS  PubMed  Google Scholar 

  90. Hill LD, York TP, Kusanovic JP, Gomez R, Eaves LJ, Romero R, Strauss JF 3rd (2011) Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. PLoS ONE 6(1):e16681. doi:10.1371/journal.pone.0016681

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  91. Goddard KA, Tromp G, Romero R, Olson JM, Lu Q, Xu Z, Parimi N, Nien JK, Gomez R, Behnke E, Solari M, Espinoza J, Santolaya J, Chaiworapongsa T, Lenk GM, Volkenant K, Anant MK, Salisbury BA, Carr J, Lee MS, Vovis GF, Kuivaniemi H (2007) Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPS in 190 genes. Hum Hered 63(1):1–16. doi:10.1159/000097926

    Article  CAS  PubMed  Google Scholar 

  92. Gopec Consortium (2005) Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet 77(1):127–131. doi:10.1086/431245

    Article  PubMed Central  Google Scholar 

  93. McCarthy MI, Hirschhorn JN (2008) Genome-wide association studies: past, present and future. Hum Mol Genet 17(R2):R100–R101. doi:10.1093/hmg/ddn298

    Article  CAS  PubMed  Google Scholar 

  94. Lockwood C, Wendel G (2011) Practice bulletin no. 124: inherited thrombophilias in pregnancy. Obstet Gynecol 118(3):730–740. doi:10.1097/AOG.0b013e3182310c6f

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, China

    Xing Li, Ya L. Luo, Qiong H. Zhang & Qing Chen

  2. Division of Epidemiology, School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China

    Chen Mao

  3. Bao’an Maternal and Child Health Hospital, Shenzhen, China

    Xi W. Wang

  4. Traditional Chinese Medicine Hospital of Zhejiang, Hangzhou, China

    Shan Liu

Authors
  1. Xing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ya L. Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiong H. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chen Mao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xi W. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Qing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qing Chen.

Additional information

Xing Li, Ya L. Luo have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Luo, Y.L., Zhang, Q.H. et al. Methylenetetrahydrofolate reductase gene C677T, A1298C polymorphisms and pre-eclampsia risk: a meta-analysis. Mol Biol Rep 41, 5435–5448 (2014). https://doi.org/10.1007/s11033-014-3415-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-014-3415-z

Keywords

Search

Navigation